Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

179 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Anti-miR-17 therapy delays tumorigenesis in MYC-driven hepatocellular carcinoma (HCC).
Dhanasekaran R, Gabay-Ryan M, Baylot V, Lai I, Mosley A, Huang X, Zabludoff S, Li J, Kaimal V, Karmali P, Felsher DW. Dhanasekaran R, et al. Among authors: felsher dw. Oncotarget. 2017 Nov 9;9(5):5517-5528. doi: 10.18632/oncotarget.22342. eCollection 2018 Jan 19. Oncotarget. 2017. PMID: 29464015 Free PMC article.
Oncogene addiction: resetting the safety switch?
Li Y, Choi PS, Felsher DW. Li Y, et al. Among authors: felsher dw. Oncotarget. 2014 Sep 30;5(18):7986-7. doi: 10.18632/oncotarget.2474. Oncotarget. 2014. PMID: 25275297 Free PMC article. No abstract available.
Metabolic vulnerabilities of MYC-induced cancer.
Gouw AM, Toal GG, Felsher DW. Gouw AM, et al. Among authors: felsher dw. Oncotarget. 2016 May 24;7(21):29879-80. doi: 10.18632/oncotarget.7223. Oncotarget. 2016. PMID: 26863454 Free PMC article. No abstract available.
MYC regulates the antitumor immune response through CD47 and PD-L1.
Casey SC, Tong L, Li Y, Do R, Walz S, Fitzgerald KN, Gouw AM, Baylot V, Gütgemann I, Eilers M, Felsher DW. Casey SC, et al. Among authors: felsher dw. Science. 2016 Apr 8;352(6282):227-31. doi: 10.1126/science.aac9935. Epub 2016 Mar 10. Science. 2016. PMID: 26966191 Free PMC article.
MYC: Master Regulator of Immune Privilege.
Casey SC, Baylot V, Felsher DW. Casey SC, et al. Among authors: felsher dw. Trends Immunol. 2017 Apr;38(4):298-305. doi: 10.1016/j.it.2017.01.002. Epub 2017 Feb 21. Trends Immunol. 2017. PMID: 28233639 Free PMC article. Review.
Administration of low-dose combination anti-CTLA4, anti-CD137, and anti-OX40 into murine tumor or proximal to the tumor draining lymph node induces systemic tumor regression.
Hebb JPO, Mosley AR, Vences-Catalán F, Rajasekaran N, Rosén A, Ellmark P, Felsher DW. Hebb JPO, et al. Among authors: felsher dw. Cancer Immunol Immunother. 2018 Jan;67(1):47-60. doi: 10.1007/s00262-017-2059-y. Epub 2017 Sep 13. Cancer Immunol Immunother. 2018. PMID: 28905118 Free PMC article.
179 results